Companies /Healthcare

Viridian Therapeutics Inc

NASDAQ: VRDN Biotechnology

$20.00

▼ $0.58 (−2.80%) today

Markets closed · 6:33am ET

Fundamentals

Market Cap

$2.3B

Revenue (TTM)

$71.1M

EPS (TTM)

$-3.42

52-Week Range

$13 – $34

Street Target

$36.75

About Viridian Therapeutics

Viridian Therapeutics, Inc., based in Waltham, Massachusetts, is a biotechnology firm focused on developing treatments for serious and rare diseases. Its leading projects include VRDN-001, a monoclonal antibody for thyroid eye disease, now in Phase 3 trials, and VRDN-003, a next-generation antibody with potential for the same condition. The company also explores treatments for autoimmune diseases through its preclinical programs VRDN-006 and VRDN-008. Founded in 2010 and originally known as Miragen Therapeutics, it rebranded to Viridian Therapeutics in 2021.

VRDN Coverage

8:45am ET

Investing

Huge Insider Buying in MGM and Salesforce

As the year winds down, insiders make huge buys in MGM Resorts and Salesforce. However, those were not the only notable instances of insider buying seen recently.

AMR AVTR CBIO

Trey Thoelcke

2:21pm ET

Investing

Insiders Are Buying These 3 Stocks Hand Over Fist

Insider buys can be a telltale sign of a turnaround, as these investments give you a window into where management stands with a company. Studies have shown that insider buys often lead…

SMMT VANI VRDN

Omor Ibne Ehsan

9:15am ET

Investing

Last Week’s 3 Biotech IPOs Prompt Huge Insider Buying

IPOs at three biotechs last week tempted insiders to make huge purchases of shares. This effect spilled over into buying at a couple of other biotechs as well.

PI VRDN

Trey Thoelcke

1:09pm ET

Investing

Huge Insider Buys From Warren Buffett, Jack Ma, Carlos Slim and More

Recent insider buying has been highlighted by purchases by Warren Buffett, Jack Ma, Carlos Slim, and John Paulson. Biotechs tempted insiders, as did public offerings.

BABA CALC EWTX

Trey Thoelcke